Yesterday, OMB’s Office of Information and Regulatory Affairs (OIRA) announced that it had received an interim final rule (IFR) from the USDA’s Animal and Plant Health Inspection Service (APHIS) on “Regulatory Efficiencies for Products of Biotechnology”.
According to the Spring 2025 Unified Agenda entry for this rulemaking:
“This interim rule will among other things, create exemptions from USDA’s regulations for plants and microbes that are already subject to EPA regulation and products USDA previously reviewed and deregulated, and provide a permitting exemption for certain modified organisms that are commonly used in laboratory development of products of biotechnology. Other changes are also contemplated.”
While that ‘other changes’ comment may change how I look at this rulemaking, I do not currently expect to cover this in any depth. Due to my interest in biotechnology manufacturing safety and security, I would expect to at least mention the publication of this IFR in the appropriate Short Takes post.
Posts
No comments:
Post a Comment